Einat Brill Almon

2014

In 2014, Einat Brill Almon earned a total compensation of $678.8K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 27% decrease compared to previous year.

Compensation breakdown

Bonus$85,000
Option Awards$56,170
Salary$263,917
Stock Awards$205,244
Other$68,489
Total$678,820

Almon received $263.9K in salary, accounting for 39% of the total pay in 2014.

Almon also received $85K in bonus, $56.2K in option awards, $205.2K in stock awards and $68.5K in other compensation.

Rankings

In 2014, Einat Brill Almon's compensation ranked 9,184th out of 13,032 executives tracked by ExecPay. In other words, Almon earned more than 29.5% of executives.

ClassificationRankingPercentile
All
9,184
out of 13,032
30th
Division
Manufacturing
3,446
out of 4,966
31st
Major group
Chemicals And Allied Products
1,164
out of 1,686
31st
Industry group
Drugs
923
out of 1,365
32nd
Industry
Biological Products, Except Diagnostic Substances
166
out of 236
30th
Source: SEC filing on March 16, 2017.

Almon's colleagues

We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2014.

2014

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2014

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2014

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

2014

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

News

You may also like